Therapy-Related Neoplasm

cancer family

Identifier: CI-CAN-00000364
Entity page: /cancer/therapy-related-neoplasm ↗
Edges: 147

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Therapy-Related Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 51show all (up to 200)
→ investigated in trials for	Cytarabinesmall molecule 18 trials (8 active) · roll-up of the cancer and its descendants	—	—	Therapy-Related Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule

Therapy-Related Neoplasm studied in …STUDIED_INderived10 of 96show all (up to 200)
→ studied in	NCT05880160NA · completed Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction · condition mapped ALIAS · 96 trials mapped (37 active)	—	—	Therapy-Related Malignant Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02619682Phase 2 · completed Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 96 trials mapped (37 active)	—	—	Transplant-Related Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT07012044Phase 1 · recruiting A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT05554406Phase 2 · recruiting Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped ALIAS · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT01861314Phase 1 · active not recruiting Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT03953898Phase 2 · active not recruiting Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation · condition mapped ONTOLOGY_EXACT · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT04782752NA · recruiting Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination · condition mapped ALIAS · 96 trials mapped (37 active)	—	—	Transplant-Related Lung Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04269213Phase 2 · completed CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old · condition mapped ALIAS · 96 trials mapped (37 active)	—	—	Acute Myeloid Leukemia Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains